Description

ZYLOMOX CV Injection is a broad-spectrum antibacterial formulation that combines Amoxicillin, a penicillin-class antibiotic, with Clavulanic Acid, a beta-lactamase inhibitor. This synergistic combination enhances antibacterial efficacy against both gram-positive and gram-negative bacteria, especially those producing beta-lactamase enzymes, which typically render other antibiotics ineffective.

Developed and manufactured by BLUEPILL EXPRESS, a globally recognized pharmaceutical exporter, ZYLOMOX CV Injection is extensively used for managing moderate to severe infections in healthcare settings. The addition of Clavulanic Acid allows Amoxicillin to act against resistant strains, making it an ideal first-line therapy in many hospital protocols.

• Beta-lactam Antibiotic

• Penicillin with Beta-Lactamase Inhibitor

• Amoxicillin (as sodium): 1.2 g (may vary depending on SKU – 600 mg, 3 g also available)

• Clavulanic Acid (as potassium): proportionate to formulation

• Reconstitution required before intravenous administration

• Effective against beta-lactamase-producing bacteria

• Ideal for severe respiratory, urinary, skin, and soft tissue infections

• Quick onset of action with IV delivery

• Manufactured under WHO-GMP certified facilities

• Widely accepted in public and private hospital sectors

• Export-ready with all international documentation

• Community-acquired pneumonia

• Complicated urinary tract infections

• Intra-abdominal infections

• Post-surgical infections

• Skin and soft tissue infections

• Septicemia and bone infections

• ENT infections with high resistance patterns

• Adult standard dose: 1.2 g every 8 hours via IV infusion

• Reconstituted with sterile water for injection

• Administered over 3–5 minutes (IV bolus) or 15–30 minutes (IV infusion)

• Dosage adjustments for renal or hepatic impairment

• Dissolve the contents in the appropriate diluent

• Use immediately after reconstitution

• Administer under the supervision of qualified healthcare personnel

• Complete the full course of treatment to prevent resistance

• Known hypersensitivity to penicillin or beta-lactam antibiotics

• Use cautiously in patients with hepatic dysfunction

• Monitor renal function and blood counts during prolonged therapy

• May interfere with some laboratory tests (e.g., urine glucose)

• Diarrhea

• Nausea and vomiting

• Rash or allergic reactions

• Elevated liver enzymes

• Rarely, anaphylaxis or Clostridioides difficile-associated diarrhea

• Form: Dry powder for injection

• Pack Type: Glass vial with flip-off seal

• Strengths Available: 600 mg / 1.2 g / 3 g (custom bulk supply)

• Shelf Life: 24 months under recommended conditions

• Storage: Store below 25°C. Protect from moisture and light

• Certifications: WHO-GMP, ISO 9001:2015, DCGI, and country-specific approvals available

BLUEPILL EXPRESS, India’s trusted third-party manufacturing and merchant export partner for high-quality pharmaceutical formulations. Specializing in injectables, oral solids, nutraceuticals, and APIs, BLUEPILL EXPRESS serves clients in Asia, Africa, LATAM, CIS, and the Middle East with end-to-end export support.

• Complies with global pharmacopeial standards (IP/USP/BP)

• Custom branding and private label options

• Full regulatory support – COA, MSDS, stability data, export documentation

• Available for government tenders and hospital supply chains

• Scalable production capacity with fast global shipping